RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Xinbin Gu to Immunotoxins

Back to Details
This is a "connection" page, showing publications Xinbin Gu has written about Immunotoxins.
Xinbin Gu
Connection Strength
1.208
Immunotoxins
  1. Xie G, Shan L, Yang C, Liu Y, Pang X, Teng S, Wu TC, Gu X. Recombinant immunotoxin induces tumor intrinsic STING signaling against head and neck squamous cell carcinoma. Sci Rep. 2023 10 28; 13(1):18476.
    View in: PubMed
    Score: 0.932
  2. Zhu S, Liu Y, Wang PC, Gu X, Shan L. Recombinant Immunotoxin Therapy of Glioblastoma: Smart Design, Key Findings, and Specific Challenges. Biomed Res Int. 2017; 2017:7929286.
    View in: PubMed
    Score: 0.150
  3. Meng J, Liu Y, Gao S, Lin S, Gu X, Pomper MG, Wang PC, Shan L. A bivalent recombinant immunotoxin with high potency against tumors with EGFR and EGFRvIII expression. Cancer Biol Ther. 2015; 16(12):1764-74.
    View in: PubMed
    Score: 0.126
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support